NCT03697343: Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

NCT03697343
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Phase 3
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must have 1-4 cerebral metastases suitable for local radiotherapy
Exclusions: Patients with prior irradiation of the cerebral metastasis to be treated in the study; Patients with metastasis in the brainstem; Patients with more than 6 cerebral metastases including the patient’s prior history
https://ClinicalTrials.gov/show/NCT03697343

Comments are closed.

Up ↑